• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis. Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Th

Giuseppe

Emeritus
[Source: The Journal of Infectious Diseases, full page: (LINK). Abstract, edited.]


Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Therapy of Wound Infections


E. Lesho 1,a, E. J. Yoon 5, P. McGann 1, E. Snesrud 1, Y. Kwak 1, M. Milillo 1, F. Onmus-Leone 1, L. Preston 1, K. St. Clair 3, M. Nikolich 2, H. Viscount 4, G. Wortmann 3, M. Zapor 3, C. Grillot-Courvalin 5, P. Courvalin 5, R. Clifford 1 and P. E. Waterman 1

Author Affiliations: <SUP>1</SUP>Multidrug-Resistant Organism Repository and Surveillance Network <SUP>2</SUP>Department of Emerging Bacterial Infections, Walter Reed Army Institute of Research, Silver Spring <SUP>3</SUP>Infectious Diseases Service <SUP>4</SUP>Department of Pathology, Walter Reed National Military Medical Center, Bethesda, Maryland <SUP>5</SUP>Unit? des Agents Antibact?riens, Institut Pasteur, Paris, France

Correspondence: Emil Lesho, 503 Robert Grant Ave, Silver Spring, MD 20910 (emil.lesho@us.army.mil).

Presented in part: American Society of Microbiology General Meeting June 16th?19th, 2012, San Francisco, California; Poster 653; Wellcome Trust 2012 Infectious Disease Genomics & Global Health Scientific Conference October 1st?3rd 2012, Cambridge, United Kingdom: Poster# P4.


Abstract

Background.

Colistin resistance is of concern since it is increasingly needed to treat infections caused by bacteria resistant to all other antibiotics and has been associated with poorer outcomes. Longitudinal data from in vivo series are sparse.


Methods.

Under a quality-improvement directive to intensify infection-control measures, extremely drug-resistant (XDR) bacteria undergo phenotypic and molecular analysis.


Results.

Twenty-eight XDR Acinetobacter baumannii isolates were longitudinally recovered during colistin therapy. Fourteen were susceptible to colistin, and 14 were resistant to colistin. Acquisition of colistin resistance did not alter resistance to other antibiotics. Isolates had low minimum inhibitory concentrations of an investigational aminoglycoside, belonged to multi-locus sequence type 94, were indistinguishable by pulsed-field gel electrophoresis and optical mapping, and harbored a novel pmrC1A1B allele. Colistin resistance was associated with point mutations in the pmrA1 and/or pmrB genes. Additional pmrC homologs, designated eptA-1 and eptA-2, were at distant locations from the operon. Compared with colistin-susceptible isolates, colistin-resistant isolates displayed significantly enhanced expression of pmrC1A1B, eptA-1, and eptA-2; lower growth rates; and lowered fitness. Phylogenetic analysis suggested that colistin resistance emerged from a single progenitor colistin-susceptible isolate.


Conclusions.

We provide insights into the in vivo evolution of colistin resistance in a series of XDR A. baumannii isolates recovered during therapy of infections and emphasize the importance of antibiotic stewardship and surveillance.


Key words

Colistin-resistant Acinetobacter baumannii - infection control - translational research

Received December 14, 2012. Accepted March 13, 2013.

Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2013. This work is written by (a) US Government employee(s) and is in the public domain in the US.


-
-------
 
Back
Top Bottom